What indication does Boo have that the steps the board is taking "in the right direction" aren't just to sell the entire company on the cheap to their best friends at the next financing. This has been the pattern with this company and the non-invasive critical care glucose monitor since before it was called Echo. What's different now?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.